|
Associated RNAi Experiments
InterPro
Analysis Name: InterproScan 5
Date Performed: 2014-05-02
IPR Term | IPR Description | Source | Source Term | Source Description | Alignment |
None | No IPR available | PRINTS | PR00011 | EGFLAMININ | coord: 22..40 score: 49.28 coord: 520..538 score: 50.72 coord: 450..468 score: 51.44 |
None | No IPR available | GENE3D | 2.10.25.10 | | coord: 186..215 e-value: 1.0E-4 score: 21.4 |
None | No IPR available | GENE3D | 2.170.300.10 | | coord: 409..508 e-value: 2.1E-8 score: 33.6 coord: 10..127 e-value: 1.2E-19 score: 69.9 coord: 509..582 e-value: 2.0E-10 score: 40.1 coord: 216..316 e-value: 3.9E-13 score: 48.9 |
None | No IPR available | GENE3D | 2.10.25.10 | | coord: 334..360 e-value: 5.6E-4 score: 19.3 |
None | No IPR available | GENE3D | 2.10.25.10 | | coord: 374..405 e-value: 5.2E-4 score: 19.3 |
None | No IPR available | PANTHER | PTHR24035 | MULTIPLE EPIDERMAL GROWTH FACTOR-LIKE DOMAINS PROTEIN | coord: 1..584 |
None | No IPR available | TMHMM | TMhelix | | coord: 617..639 |
IPR000742 | Epidermal growth factor-like domain | SMART | SM00181 | EGF | coord: 181..213 e-value: 0.019 score: 24.1 coord: 439..469 e-value: 28.0 score: 10.8 coord: 550..582 e-value: 41.0 score: 9.0 coord: 9..41 e-value: 0.66 score: 19.0 coord: 406..437 e-value: 220.0 score: 0.6 coord: 241..273 e-value: 0.39 score: 19.8 coord: 138..170 e-value: 0.32 score: 20.1 coord: 284..316 e-value: 0.0047 score: 26.1 coord: 361..404 e-value: 73.0 score: 6.1 coord: 327..359 e-value: 0.71 score: 18.9 coord: 499..539 e-value: 0.36 score: 19.9 coord: 95..127 e-value: 0.01 score: 25.0 coord: 52..84 e-value: 1.6 score: 17.7 |
IPR000742 | Epidermal growth factor-like domain | PROSITE | PS50026 | EGF_3 | coord: 281..316 score: 10.864 |
IPR000742 | Epidermal growth factor-like domain | PROSITE | PS50026 | EGF_3 | coord: 238..273 score: 7.03 |
IPR000742 | Epidermal growth factor-like domain | PROSITE | PS50026 | EGF_3 | coord: 183..213 score: 11.113 |
IPR000742 | Epidermal growth factor-like domain | PROSITE | PS50026 | EGF_3 | coord: 329..359 score: 11.83 |
IPR000742 | Epidermal growth factor-like domain | PROSITE | PS50026 | EGF_3 | coord: 54..84 score: 8.624 |
IPR000742 | Epidermal growth factor-like domain | PROSITE | PS50026 | EGF_3 | coord: 140..170 score: 10.068 |
IPR000742 | Epidermal growth factor-like domain | PROSITE | PS50026 | EGF_3 | coord: 504..539 score: 10.955 |
IPR000742 | Epidermal growth factor-like domain | PROSITE | PS50026 | EGF_3 | coord: 92..127 score: 10.976 |
IPR000742 | Epidermal growth factor-like domain | PROSITE | PS50026 | EGF_3 | coord: 6..41 score: 10.011 |
IPR002049 | EGF-like, laminin | SMART | SM00180 | EGF_Lam | coord: 57..96 e-value: 4.2 score: 3.7 coord: 289..328 e-value: 1.7 score: 8.6 coord: 143..182 e-value: 0.19 score: 20.4 coord: 332..371 e-value: 0.26 score: 18.8 coord: 100..139 e-value: 5.2 score: 2.7 coord: 14..53 e-value: 2.0 score: 7.8 coord: 375..423 e-value: 0.79 score: 12.7 coord: 440..481 e-value: 1.2 score: 10.5 coord: 246..285 e-value: 0.02 score: 24.1 coord: 512..551 e-value: 2.6E-4 score: 30.4 |
IPR002049 | EGF-like, laminin | PFAM | PF00053 | Laminin_EGF | coord: 332..369 e-value: 0.0013 score: 18.4 coord: 246..291 e-value: 9.2E-4 score: 18.9 coord: 375..408 e-value: 0.0019 score: 18.0 coord: 512..555 e-value: 7.1E-4 score: 19.3 |
IPR013032 | EGF-like, conserved site | PFAM | PF12661 | hEGF | coord: 157..169 e-value: 0.0082 score: 16.0 coord: 303..315 e-value: 0.018 score: 14.9 |
IPR013032 | EGF-like, conserved site | PROSITE | PS01186 | EGF_2 | coord: 392..407 |
IPR013032 | EGF-like, conserved site | PROSITE | PS00022 | EGF_1 | coord: 570..581 |
IPR013032 | EGF-like, conserved site | PROSITE | PS01186 | EGF_2 | coord: 72..87 |
IPR013032 | EGF-like, conserved site | PROSITE | PS00022 | EGF_1 | coord: 304..315 |
IPR013032 | EGF-like, conserved site | PROSITE | PS00022 | EGF_1 | coord: 158..169 |
IPR013032 | EGF-like, conserved site | PROSITE | PS01186 | EGF_2 | coord: 158..173 |
IPR013032 | EGF-like, conserved site | PROSITE | PS00022 | EGF_1 | coord: 115..126 |
IPR013032 | EGF-like, conserved site | PROSITE | PS01186 | EGF_2 | coord: 29..44 |
IPR013032 | EGF-like, conserved site | PROSITE | PS01186 | EGF_2 | coord: 527..542 |
IPR013032 | EGF-like, conserved site | PROSITE | PS00022 | EGF_1 | coord: 457..468 |
IPR013032 | EGF-like, conserved site | PROSITE | PS01186 | EGF_2 | coord: 570..581 |
IPR013032 | EGF-like, conserved site | PROSITE | PS01186 | EGF_2 | coord: 412..427 |
IPR013032 | EGF-like, conserved site | PROSITE | PS00022 | EGF_1 | coord: 347..358 |
IPR013032 | EGF-like, conserved site | PROSITE | PS00022 | EGF_1 | coord: 201..212 |
IPR013032 | EGF-like, conserved site | PROSITE | PS00022 | EGF_1 | coord: 261..272 |
IPR013032 | EGF-like, conserved site | PROSITE | PS00022 | EGF_1 | coord: 29..40 |
IPR013032 | EGF-like, conserved site | PROSITE | PS01186 | EGF_2 | coord: 261..276 |
IPR013032 | EGF-like, conserved site | PROSITE | PS01186 | EGF_2 | coord: 347..362 |
IPR013032 | EGF-like, conserved site | PROSITE | PS01186 | EGF_2 | coord: 304..319 |
IPR013032 | EGF-like, conserved site | PROSITE | PS00022 | EGF_1 | coord: 72..83 |
IPR013032 | EGF-like, conserved site | PROSITE | PS00022 | EGF_1 | coord: 392..403 |
IPR013032 | EGF-like, conserved site | PROSITE | PS01186 | EGF_2 | coord: 457..472 |
IPR013032 | EGF-like, conserved site | PROSITE | PS01186 | EGF_2 | coord: 201..212 |
IPR013032 | EGF-like, conserved site | PROSITE | PS00022 | EGF_1 | coord: 527..538 |
IPR013032 | EGF-like, conserved site | PROSITE | PS01186 | EGF_2 | coord: 115..130 |
Analyses
This polypeptide is derived from or has results from the following analyses
Cross References
External references for this polypeptide
Relationships
This polypeptide derives from the following mRNA feature(s):
Sequences
The following sequences are available for this feature:
polypeptide sequence >EMLSAP00000011978 ID=EMLSAP00000011978|Name=EMLSAP00000011978|organism=Lepeophtheirus salmonis|type=polypeptide|length=878bp CPSGKWGPDCGNDCPCLNGAKCDPLTGECTCTPGWQGTQCNIKCPYRSFG QDCKERCKCQNRGNCDHISGRCNCTAGWRGALCEEPCPPGTHGTECKSSC QCQNGGSCHPVDGKCYCPKGWTGQVCANPCPSGSFGLNCKEKCDCYNGGL CHHVNGQCQCLPGYKGDKCQEQCPHNLYGRNCESPCECQNGGTCNPVDGS CLCPEGWIGHYCETRNCTASDPGYAGFHCHRPCPIYTFGKDCKEVCDCKN DAFCNPVNGVCTCAPGFLGSKCDTRCPEGFFGRECQYKCQCRNGAKCHSA AGKCDCPPGWKGIFCDTPCPKGLYGKDCLEECQCKNGASCNHVNGECRCL SGYHGKHCEVPCERGYYGIGCSYRCPCHQMNSEGCDPVTGKCICKTGWRG VKCESICERGRCVCELGYSDRFCDRPCPKGYYGVACKQACPPCSSGYGFC NYISGQCECEPGFSGFFCDXPCPEGTFGRRCMGRCSCKNNAQCFHFNGEC RWSYGPNCTHECYCQNEASCNPVDGRCKCKPGYTGTRCEELCPEGYWGED CYQACRCRNSNFVCHPIRGCICRPGFAGKDCDVPLKDILRRRESSLSPSQ NGNRNRGFVYYLAQDAGTLTGIAFIILLIAFIIFLFVYYKFYSRFKRFKS ELAHAVHYTADPPHLQHQLPNSSEDDYYHHFDNPVYTSSFSRNHPRPVTI TNPATMHRCSTINNSYSRVVNRFRPPKNTNTQRDIMMKRYNREGGLGPED DEEEESDNEKGSFGCASGAFSYSTLNTKKNNDADMAQELKPHYHSTSTLK SVKSSETDLNKSYPILLDVQESGRLIASNTSGISPMTKEREEDDKKEPDS GVSSAKSTAATPWSNEEEQESSLLTSTS back to top
|